Bicycle Therapeutics PLC (BCYC)
20.74
+0.48
(+2.37%)
USD |
NASDAQ |
Nov 22, 11:26
Bicycle Therapeutics Revenue (Quarterly): 2.676M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.676M |
| June 30, 2024 | 9.361M |
| March 31, 2024 | 19.53M |
| December 31, 2023 | 5.331M |
| September 30, 2023 | 5.352M |
| June 30, 2023 | 11.40M |
| March 31, 2023 | 4.896M |
| December 31, 2022 | 3.185M |
| September 30, 2022 | 3.04M |
| June 30, 2022 | 4.378M |
| March 31, 2022 | 3.86M |
| December 31, 2021 | 3.771M |
| September 30, 2021 | 4.333M |
| June 30, 2021 | 1.785M |
| Date | Value |
|---|---|
| March 31, 2021 | 1.808M |
| December 31, 2020 | 3.848M |
| September 30, 2020 | 3.842M |
| June 30, 2020 | 1.571M |
| March 31, 2020 | 1.129M |
| December 31, 2019 | 5.281M |
| September 30, 2019 | 0.614M |
| June 30, 2019 | 1.522M |
| March 31, 2019 | 6.384M |
| December 31, 2018 | 1.057M |
| September 30, 2018 | 1.61M |
| June 30, 2018 | 1.661M |
| March 31, 2018 | 2.808M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.129M
Minimum
Mar 2020
19.53M
Maximum
Mar 2024
5.019M
Average
3.854M
Median
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.80M |
| Total Expenses (Quarterly) | 66.20M |
| EPS Diluted (Quarterly) | -0.74 |
| Enterprise Value | 508.01M |
| Profit Margin (Quarterly) | -1.90K% |
| Earnings Yield | -15.86% |
| Normalized Earnings Yield | -15.81 |